InterCure Ltd. INCR
Set alert
4.05 USD +0.05 +1.19%
At close · Nov 2
4.05 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
4.03 Day range 4.32
3.40 52-week range 7.55
- YTD
- -10.99%
- 1 year
- -42.14%
- Open
- 4.03
- Prev close
- 4.00
- Mkt cap
- 60.77M
- Vol
- 12.15K
- Avg vol
- 22.19K
- EPS
- -0.95
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.03
- High
- 4.32
- Forward P/E
- -1.21
- Beta
- 0.03
- Short ratio
- 0.73
- Inst. own
- 11.61%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.52
- 200-d avg
- 2.14
- 1y target
- 0.00
3M chart
Events in this range
- Aug 24, 2026Split: 1 for 5
Signals (23)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 30, 2026 | 3 days ago |
| SMA: Bearish | Oct 12, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 7, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 6, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 6, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 5, 2026 | 4 weeks ago |
| SMA: Bullish | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 25, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 9, 2026 | 1 month ago |
| SMA: Bullish | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 24, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 24, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 20, 2026 | 2 months ago |
| SMA: Bearish | Aug 19, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 14, 2026 | 2 months ago |
| SMA: Bullish | Aug 14, 2026 | 2 months ago |
| SMA: Bearish | Aug 13, 2026 | 2 months ago |
| SMA: Bullish | Aug 12, 2026 | 2 months ago |
Newest 20 of 23.
Key statistics
- Market cap
- 81.92M
- Enterprise value
- 203.36M
- Trailing P/E
- 0.00
- Forward P/E
- -1.21
- PEG ratio
- 0.00
- Price / sales
- 0.30
- Price / book
- 0.19
- EPS (TTM)
- -0.38
- Beta
- 0.03
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -24.07%
- Revenue (TTM)
- 272.67M
- Revenue growth
- -38.60%
- Free cash flow
- 0
- Total cash
- 20.30M
- Total debt
- 150.81M
- Return on equity
- -13.61%
- Shares outstanding
- 45.77M
- Short % of float
- 0.15%
- 50-day average
- 1.52
- 200-day average
- 2.14
Analyst view
Consensus: none
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
INCR Revenue — quarterly 102.44M
INCR Net income — quarterly 4.88M
INCR EPS — quarterly 0.525
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 31, 2023 | Jun 1, 2023 | 0.00 | 0.03 | — | — |
| May 15, 2023 | Mar 1, 2023 | 0.00 | 0.00 | — | — |
| Mar 31, 2023 | Dec 1, 2022 | 0.00 | 0.05 | — | — |
| Nov 15, 2022 | Sep 1, 2022 | 0.00 | 0.05 | — | — |
| Aug 15, 2022 | Jun 1, 2022 | 0.00 | 0.10 | — | — |
| May 16, 2022 | Mar 1, 2022 | 0.00 | 0.11 | — | — |
About InterCure Ltd.
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Israel
- Website
- intercure.co
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on INCR — it syncs with the Stock Master app.